nodes	percent_of_prediction	percent_of_DWPC	metapath
Methylergometrine—Pergolide—ADRA1D—polycystic ovary syndrome	0.00667	0.113	CrCbGaD
Methylergometrine—Lisuride—ADRA1D—polycystic ovary syndrome	0.00579	0.0979	CrCbGaD
Methylergometrine—Pergolide—ADRA1B—polycystic ovary syndrome	0.00569	0.0963	CrCbGaD
Methylergometrine—Ergonovine—ADRA1A—polycystic ovary syndrome	0.00567	0.0959	CrCbGaD
Methylergometrine—Ergotamine—ADRA1D—polycystic ovary syndrome	0.00556	0.0941	CrCbGaD
Methylergometrine—Bromocriptine—ADRA1D—polycystic ovary syndrome	0.00536	0.0907	CrCbGaD
Methylergometrine—Lisuride—ADRA1B—polycystic ovary syndrome	0.00494	0.0835	CrCbGaD
Methylergometrine—Ergotamine—ADRA1B—polycystic ovary syndrome	0.00475	0.0803	CrCbGaD
Methylergometrine—Bromocriptine—ADRA1B—polycystic ovary syndrome	0.00458	0.0774	CrCbGaD
Methylergometrine—Pergolide—ADRA1A—polycystic ovary syndrome	0.00383	0.0648	CrCbGaD
Methylergometrine—Ergotamine—ADRA1A—polycystic ovary syndrome	0.00319	0.054	CrCbGaD
Methylergometrine—Bromocriptine—ADRA1A—polycystic ovary syndrome	0.00308	0.0521	CrCbGaD
Methylergometrine—HTR2B—Signaling Pathways—SCT—polycystic ovary syndrome	0.000188	0.0002	CbGpPWpGaD
Methylergometrine—HTR1E—Signaling Pathways—NGFR—polycystic ovary syndrome	0.000187	0.000199	CbGpPWpGaD
Methylergometrine—HTR1F—Signaling Pathways—ADRB2—polycystic ovary syndrome	0.000186	0.000198	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling Pathways—FSHR—polycystic ovary syndrome	0.000186	0.000198	CbGpPWpGaD
Methylergometrine—HTR1E—Signaling by GPCR—POMC—polycystic ovary syndrome	0.000186	0.000197	CbGpPWpGaD
Methylergometrine—HTR2B—Signaling by GPCR—ADRB2—polycystic ovary syndrome	0.000185	0.000197	CbGpPWpGaD
Methylergometrine—HTR1E—Signaling Pathways—PRL—polycystic ovary syndrome	0.000185	0.000197	CbGpPWpGaD
Methylergometrine—DRD1—Signaling Pathways—GNRH1—polycystic ovary syndrome	0.000185	0.000196	CbGpPWpGaD
Methylergometrine—HTR2C—GPCR ligand binding—POMC—polycystic ovary syndrome	0.000182	0.000193	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling by GPCR—GHRL—polycystic ovary syndrome	0.000181	0.000192	CbGpPWpGaD
Methylergometrine—HTR2B—Signaling Pathways—MTNR1B—polycystic ovary syndrome	0.000179	0.00019	CbGpPWpGaD
Methylergometrine—DRD1—Signaling Pathways—AKR1C1—polycystic ovary syndrome	0.000179	0.00019	CbGpPWpGaD
Methylergometrine—DRD1—GPCR downstream signaling—GNAS—polycystic ovary syndrome	0.000179	0.00019	CbGpPWpGaD
Methylergometrine—HTR1E—Signaling by GPCR—AKT2—polycystic ovary syndrome	0.000178	0.00019	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling Pathways—PDE3B—polycystic ovary syndrome	0.000177	0.000188	CbGpPWpGaD
Methylergometrine—DRD1—Signaling Pathways—SCT—polycystic ovary syndrome	0.000177	0.000188	CbGpPWpGaD
Methylergometrine—HTR2B—Signaling Pathways—FGF18—polycystic ovary syndrome	0.000176	0.000187	CbGpPWpGaD
Methylergometrine—HTR1E—Signaling Pathways—ADRB2—polycystic ovary syndrome	0.000176	0.000187	CbGpPWpGaD
Methylergometrine—DRD1—Signaling by GPCR—ADRB2—polycystic ovary syndrome	0.000175	0.000186	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling Pathways—RACGAP1—polycystic ovary syndrome	0.000175	0.000186	CbGpPWpGaD
Methylergometrine—HTR2B—Signaling Pathways—RBP4—polycystic ovary syndrome	0.000175	0.000186	CbGpPWpGaD
Methylergometrine—CYP3A4—Biological oxidations—CYP1A1—polycystic ovary syndrome	0.000174	0.000185	CbGpPWpGaD
Methylergometrine—HTR2B—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—polycystic ovary syndrome	0.000174	0.000185	CbGpPWpGaD
Methylergometrine—DRD1—Circadian rythm related genes—IL6—polycystic ovary syndrome	0.000173	0.000184	CbGpPWpGaD
Methylergometrine—HTR2A—GPCR downstream signaling—GHRL—polycystic ovary syndrome	0.000173	0.000184	CbGpPWpGaD
Methylergometrine—HTR1F—Signaling Pathways—GNAS—polycystic ovary syndrome	0.000173	0.000184	CbGpPWpGaD
Methylergometrine—HTR2B—Signaling by GPCR—GNAS—polycystic ovary syndrome	0.000172	0.000183	CbGpPWpGaD
Methylergometrine—CYP3A4—Metapathway biotransformation—CYP1A1—polycystic ovary syndrome	0.000172	0.000183	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling Pathways—ADRA1A—polycystic ovary syndrome	0.00017	0.000181	CbGpPWpGaD
Methylergometrine—DRD1—Signaling Pathways—MTNR1B—polycystic ovary syndrome	0.000169	0.00018	CbGpPWpGaD
Methylergometrine—DRD1—Signaling Pathways—FGF18—polycystic ovary syndrome	0.000166	0.000177	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling Pathways—FST—polycystic ovary syndrome	0.000166	0.000176	CbGpPWpGaD
Methylergometrine—HTR2C—GPCR downstream signaling—ADRB2—polycystic ovary syndrome	0.000165	0.000175	CbGpPWpGaD
Methylergometrine—DRD1—Signaling Pathways—RBP4—polycystic ovary syndrome	0.000165	0.000175	CbGpPWpGaD
Methylergometrine—HTR1F—Signaling Pathways—NCOR1—polycystic ovary syndrome	0.000165	0.000175	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling Pathways—ADRB3—polycystic ovary syndrome	0.000164	0.000174	CbGpPWpGaD
Methylergometrine—HTR2B—Signaling Pathways—YAP1—polycystic ovary syndrome	0.000163	0.000173	CbGpPWpGaD
Methylergometrine—HTR1E—Signaling Pathways—GNAS—polycystic ovary syndrome	0.000163	0.000173	CbGpPWpGaD
Methylergometrine—DRD1—Signaling by GPCR—GNAS—polycystic ovary syndrome	0.000162	0.000172	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling Pathways—LHB—polycystic ovary syndrome	0.000162	0.000172	CbGpPWpGaD
Methylergometrine—HTR1F—Signaling Pathways—NRG1—polycystic ovary syndrome	0.000161	0.000172	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling Pathways—FSHR—polycystic ovary syndrome	0.000161	0.000172	CbGpPWpGaD
Methylergometrine—HTR2B—Signaling Pathways—GAB1—polycystic ovary syndrome	0.000161	0.000171	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling Pathways—GNRH1—polycystic ovary syndrome	0.000158	0.000168	CbGpPWpGaD
Methylergometrine—HTR2A—GPCR ligand binding—POMC—polycystic ovary syndrome	0.000158	0.000168	CbGpPWpGaD
Methylergometrine—HTR2A—SIDS Susceptibility Pathways—IL6—polycystic ovary syndrome	0.000157	0.000167	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling by GPCR—GHRL—polycystic ovary syndrome	0.000157	0.000167	CbGpPWpGaD
Methylergometrine—HTR1E—Signaling Pathways—NCOR1—polycystic ovary syndrome	0.000155	0.000165	CbGpPWpGaD
Methylergometrine—HTR2B—Signaling Pathways—INSR—polycystic ovary syndrome	0.000154	0.000163	CbGpPWpGaD
Methylergometrine—DRD1—Signaling Pathways—YAP1—polycystic ovary syndrome	0.000154	0.000163	CbGpPWpGaD
Methylergometrine—CYP3A4—Metabolism—NMNAT3—polycystic ovary syndrome	0.000153	0.000163	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling Pathways—AKR1C1—polycystic ovary syndrome	0.000153	0.000163	CbGpPWpGaD
Methylergometrine—HTR2C—GPCR downstream signaling—GNAS—polycystic ovary syndrome	0.000153	0.000162	CbGpPWpGaD
Methylergometrine—HTR1E—Signaling Pathways—NRG1—polycystic ovary syndrome	0.000152	0.000162	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling Pathways—RACGAP1—polycystic ovary syndrome	0.000152	0.000161	CbGpPWpGaD
Methylergometrine—DRD1—Signaling Pathways—GAB1—polycystic ovary syndrome	0.000152	0.000161	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling Pathways—SCT—polycystic ovary syndrome	0.000152	0.000161	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling by GPCR—ADRB2—polycystic ovary syndrome	0.00015	0.000159	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling Pathways—ADRA1A—polycystic ovary syndrome	0.000148	0.000157	CbGpPWpGaD
Methylergometrine—HTR2B—Signaling Pathways—AKR1C3—polycystic ovary syndrome	0.000146	0.000155	CbGpPWpGaD
Methylergometrine—DRD1—Signaling Pathways—INSR—polycystic ovary syndrome	0.000145	0.000154	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling Pathways—MTNR1B—polycystic ovary syndrome	0.000145	0.000154	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling Pathways—FST—polycystic ovary syndrome	0.000144	0.000153	CbGpPWpGaD
Methylergometrine—HTR2B—Signaling Pathways—TNRC6B—polycystic ovary syndrome	0.000144	0.000153	CbGpPWpGaD
Methylergometrine—HTR2A—GPCR downstream signaling—ADRB2—polycystic ovary syndrome	0.000143	0.000152	CbGpPWpGaD
Methylergometrine—HTR2B—Signaling Pathways—PGR—polycystic ovary syndrome	0.000142	0.000151	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling Pathways—ADRB3—polycystic ovary syndrome	0.000142	0.000151	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling Pathways—FGF18—polycystic ovary syndrome	0.000142	0.000151	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling Pathways—RBP4—polycystic ovary syndrome	0.000141	0.00015	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling Pathways—LHB—polycystic ovary syndrome	0.00014	0.000149	CbGpPWpGaD
Methylergometrine—HTR2C—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—polycystic ovary syndrome	0.00014	0.000149	CbGpPWpGaD
Methylergometrine—CYP3A4—Metabolism—LPCAT2—polycystic ovary syndrome	0.00014	0.000149	CbGpPWpGaD
Methylergometrine—CYP3A4—Metabolism—SUOX—polycystic ovary syndrome	0.00014	0.000149	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling by GPCR—GNAS—polycystic ovary syndrome	0.000139	0.000147	CbGpPWpGaD
Methylergometrine—HTR1F—Signaling Pathways—IRS2—polycystic ovary syndrome	0.000138	0.000147	CbGpPWpGaD
Methylergometrine—DRD1—Signaling Pathways—AKR1C3—polycystic ovary syndrome	0.000138	0.000146	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling Pathways—GNRH1—polycystic ovary syndrome	0.000137	0.000146	CbGpPWpGaD
Methylergometrine—DRD1—Signaling Pathways—TNRC6B—polycystic ovary syndrome	0.000136	0.000144	CbGpPWpGaD
Methylergometrine—HTR1F—Signaling Pathways—LEP—polycystic ovary syndrome	0.000135	0.000144	CbGpPWpGaD
Methylergometrine—DRD1—Signaling Pathways—PGR—polycystic ovary syndrome	0.000134	0.000143	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling Pathways—AKR1C1—polycystic ovary syndrome	0.000133	0.000141	CbGpPWpGaD
Methylergometrine—HTR2A—GPCR downstream signaling—GNAS—polycystic ovary syndrome	0.000133	0.000141	CbGpPWpGaD
Methylergometrine—HTR2B—Signaling Pathways—PLAT—polycystic ovary syndrome	0.000132	0.000141	CbGpPWpGaD
Methylergometrine—HTR2B—Signaling Pathways—GHRL—polycystic ovary syndrome	0.000132	0.000141	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling Pathways—SCT—polycystic ovary syndrome	0.000132	0.00014	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling Pathways—YAP1—polycystic ovary syndrome	0.000132	0.00014	CbGpPWpGaD
Methylergometrine—HTR1E—Signaling Pathways—IRS2—polycystic ovary syndrome	0.00013	0.000139	CbGpPWpGaD
Methylergometrine—CYP3A4—Metabolism—ISYNA1—polycystic ovary syndrome	0.00013	0.000138	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling by GPCR—ADRB2—polycystic ovary syndrome	0.00013	0.000138	CbGpPWpGaD
Methylergometrine—CYP3A4—Biological oxidations—POMC—polycystic ovary syndrome	0.00013	0.000138	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling Pathways—GAB1—polycystic ovary syndrome	0.00013	0.000138	CbGpPWpGaD
Methylergometrine—HTR1E—Signaling Pathways—LEP—polycystic ovary syndrome	0.000128	0.000136	CbGpPWpGaD
Methylergometrine—HTR2B—GPCR downstream signaling—POMC—polycystic ovary syndrome	0.000127	0.000136	CbGpPWpGaD
Methylergometrine—HTR2B—Signaling Pathways—ATF1—polycystic ovary syndrome	0.000126	0.000134	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling Pathways—MTNR1B—polycystic ovary syndrome	0.000126	0.000133	CbGpPWpGaD
Methylergometrine—DRD1—Signaling Pathways—PLAT—polycystic ovary syndrome	0.000125	0.000133	CbGpPWpGaD
Methylergometrine—DRD1—Signaling Pathways—GHRL—polycystic ovary syndrome	0.000125	0.000133	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling Pathways—INSR—polycystic ovary syndrome	0.000124	0.000132	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling Pathways—FGF18—polycystic ovary syndrome	0.000123	0.000131	CbGpPWpGaD
Methylergometrine—HTR2B—Signaling Pathways—TCF7L2—polycystic ovary syndrome	0.000123	0.000131	CbGpPWpGaD
Methylergometrine—HTR2B—GPCR downstream signaling—AKT2—polycystic ovary syndrome	0.000123	0.00013	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling Pathways—RBP4—polycystic ovary syndrome	0.000122	0.00013	CbGpPWpGaD
Methylergometrine—HTR2A—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—polycystic ovary syndrome	0.000122	0.000129	CbGpPWpGaD
Methylergometrine—HTR1F—Signaling Pathways—IRS1—polycystic ovary syndrome	0.000121	0.000128	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling by GPCR—GNAS—polycystic ovary syndrome	0.00012	0.000128	CbGpPWpGaD
Methylergometrine—DRD1—GPCR downstream signaling—POMC—polycystic ovary syndrome	0.00012	0.000128	CbGpPWpGaD
Methylergometrine—DRD1—Signaling Pathways—ATF1—polycystic ovary syndrome	0.000119	0.000127	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling Pathways—AKR1C3—polycystic ovary syndrome	0.000118	0.000125	CbGpPWpGaD
Methylergometrine—HTR2B—Signaling Pathways—NGFR—polycystic ovary syndrome	0.000117	0.000124	CbGpPWpGaD
Methylergometrine—HTR1F—Signaling Pathways—POMC—polycystic ovary syndrome	0.000116	0.000124	CbGpPWpGaD
Methylergometrine—DRD1—Signaling Pathways—TCF7L2—polycystic ovary syndrome	0.000116	0.000123	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling Pathways—TNRC6B—polycystic ovary syndrome	0.000116	0.000123	CbGpPWpGaD
Methylergometrine—HTR2B—Signaling by GPCR—POMC—polycystic ovary syndrome	0.000116	0.000123	CbGpPWpGaD
Methylergometrine—HTR1F—Signaling Pathways—INS—polycystic ovary syndrome	0.000116	0.000123	CbGpPWpGaD
Methylergometrine—DRD1—GPCR downstream signaling—AKT2—polycystic ovary syndrome	0.000116	0.000123	CbGpPWpGaD
Methylergometrine—HTR2B—Signaling Pathways—PRL—polycystic ovary syndrome	0.000115	0.000123	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling Pathways—PGR—polycystic ovary syndrome	0.000115	0.000122	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling Pathways—YAP1—polycystic ovary syndrome	0.000114	0.000121	CbGpPWpGaD
Methylergometrine—HTR1E—Signaling Pathways—IRS1—polycystic ovary syndrome	0.000114	0.000121	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling Pathways—GAB1—polycystic ovary syndrome	0.000113	0.00012	CbGpPWpGaD
Methylergometrine—HTR1F—Signaling Pathways—IGF1—polycystic ovary syndrome	0.000112	0.000119	CbGpPWpGaD
Methylergometrine—HTR1F—Signaling Pathways—AKT2—polycystic ovary syndrome	0.000112	0.000119	CbGpPWpGaD
Methylergometrine—HTR2B—Signaling by GPCR—AKT2—polycystic ovary syndrome	0.000111	0.000118	CbGpPWpGaD
Methylergometrine—CYP3A4—Metabolism—TEAD2—polycystic ovary syndrome	0.000111	0.000118	CbGpPWpGaD
Methylergometrine—CYP3A4—Metabolism—AKR1C2—polycystic ovary syndrome	0.000111	0.000118	CbGpPWpGaD
Methylergometrine—DRD1—Signaling Pathways—NGFR—polycystic ovary syndrome	0.00011	0.000117	CbGpPWpGaD
Methylergometrine—HTR1E—Signaling Pathways—POMC—polycystic ovary syndrome	0.00011	0.000117	CbGpPWpGaD
Methylergometrine—HTR2B—Signaling Pathways—ADRB2—polycystic ovary syndrome	0.00011	0.000116	CbGpPWpGaD
Methylergometrine—DRD1—Signaling by GPCR—POMC—polycystic ovary syndrome	0.000109	0.000116	CbGpPWpGaD
Methylergometrine—HTR1E—Signaling Pathways—INS—polycystic ovary syndrome	0.000109	0.000116	CbGpPWpGaD
Methylergometrine—DRD1—Signaling Pathways—PRL—polycystic ovary syndrome	0.000109	0.000116	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling Pathways—INSR—polycystic ovary syndrome	0.000108	0.000114	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling Pathways—PLAT—polycystic ovary syndrome	0.000107	0.000113	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling Pathways—GHRL—polycystic ovary syndrome	0.000107	0.000113	CbGpPWpGaD
Methylergometrine—HTR1F—Signaling Pathways—SERPINE1—polycystic ovary syndrome	0.000106	0.000113	CbGpPWpGaD
Methylergometrine—HTR1E—Signaling Pathways—IGF1—polycystic ovary syndrome	0.000106	0.000112	CbGpPWpGaD
Methylergometrine—HTR1E—Signaling Pathways—AKT2—polycystic ovary syndrome	0.000105	0.000112	CbGpPWpGaD
Methylergometrine—DRD1—Signaling by GPCR—AKT2—polycystic ovary syndrome	0.000105	0.000112	CbGpPWpGaD
Methylergometrine—DRD1—Signaling Pathways—ADRB2—polycystic ovary syndrome	0.000103	0.00011	CbGpPWpGaD
Methylergometrine—HTR2C—GPCR downstream signaling—POMC—polycystic ovary syndrome	0.000103	0.000109	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling Pathways—AKR1C3—polycystic ovary syndrome	0.000102	0.000109	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling Pathways—ATF1—polycystic ovary syndrome	0.000102	0.000108	CbGpPWpGaD
Methylergometrine—HTR2B—Signaling Pathways—GNAS—polycystic ovary syndrome	0.000102	0.000108	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling Pathways—TNRC6B—polycystic ovary syndrome	0.000101	0.000107	CbGpPWpGaD
Methylergometrine—HTR1E—Signaling Pathways—SERPINE1—polycystic ovary syndrome	0.0001	0.000106	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling Pathways—PGR—polycystic ovary syndrome	9.97e-05	0.000106	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling Pathways—TCF7L2—polycystic ovary syndrome	9.93e-05	0.000106	CbGpPWpGaD
Methylergometrine—HTR2C—GPCR downstream signaling—AKT2—polycystic ovary syndrome	9.89e-05	0.000105	CbGpPWpGaD
Methylergometrine—HTR2B—Signaling Pathways—NCOR1—polycystic ovary syndrome	9.68e-05	0.000103	CbGpPWpGaD
Methylergometrine—DRD1—Signaling Pathways—GNAS—polycystic ovary syndrome	9.58e-05	0.000102	CbGpPWpGaD
Methylergometrine—HTR2B—Signaling Pathways—NRG1—polycystic ovary syndrome	9.5e-05	0.000101	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling Pathways—NGFR—polycystic ovary syndrome	9.4e-05	9.99e-05	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling by GPCR—POMC—polycystic ovary syndrome	9.34e-05	9.93e-05	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling Pathways—PRL—polycystic ovary syndrome	9.32e-05	9.9e-05	CbGpPWpGaD
Methylergometrine—CYP3A4—Metabolism—PNPLA2—polycystic ovary syndrome	9.28e-05	9.87e-05	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling Pathways—PLAT—polycystic ovary syndrome	9.27e-05	9.85e-05	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling Pathways—GHRL—polycystic ovary syndrome	9.27e-05	9.85e-05	CbGpPWpGaD
Methylergometrine—DRD1—Signaling Pathways—NCOR1—polycystic ovary syndrome	9.13e-05	9.7e-05	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling by GPCR—AKT2—polycystic ovary syndrome	8.98e-05	9.54e-05	CbGpPWpGaD
Methylergometrine—DRD1—Signaling Pathways—NRG1—polycystic ovary syndrome	8.96e-05	9.52e-05	CbGpPWpGaD
Methylergometrine—HTR2A—GPCR downstream signaling—POMC—polycystic ovary syndrome	8.93e-05	9.49e-05	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling Pathways—ATF1—polycystic ovary syndrome	8.84e-05	9.4e-05	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling Pathways—ADRB2—polycystic ovary syndrome	8.84e-05	9.39e-05	CbGpPWpGaD
Methylergometrine—CYP3A4—Metabolism—SRD5A1—polycystic ovary syndrome	8.8e-05	9.35e-05	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling Pathways—TCF7L2—polycystic ovary syndrome	8.63e-05	9.17e-05	CbGpPWpGaD
Methylergometrine—HTR2A—GPCR downstream signaling—AKT2—polycystic ovary syndrome	8.59e-05	9.12e-05	CbGpPWpGaD
Methylergometrine—HTR1F—Signaling by GPCR—IL6—polycystic ovary syndrome	8.55e-05	9.09e-05	CbGpPWpGaD
Methylergometrine—CYP3A4—Metabolism—STAR—polycystic ovary syndrome	8.4e-05	8.92e-05	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling Pathways—GNAS—polycystic ovary syndrome	8.19e-05	8.71e-05	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling Pathways—NGFR—polycystic ovary syndrome	8.16e-05	8.68e-05	CbGpPWpGaD
Methylergometrine—HTR2B—Signaling Pathways—IRS2—polycystic ovary syndrome	8.14e-05	8.65e-05	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling by GPCR—POMC—polycystic ovary syndrome	8.11e-05	8.62e-05	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling Pathways—PRL—polycystic ovary syndrome	8.09e-05	8.6e-05	CbGpPWpGaD
Methylergometrine—HTR1E—Signaling by GPCR—IL6—polycystic ovary syndrome	8.07e-05	8.58e-05	CbGpPWpGaD
Methylergometrine—HTR2B—Signaling Pathways—LEP—polycystic ovary syndrome	7.96e-05	8.46e-05	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling Pathways—NCOR1—polycystic ovary syndrome	7.81e-05	8.3e-05	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling by GPCR—AKT2—polycystic ovary syndrome	7.8e-05	8.29e-05	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling Pathways—ADRB2—polycystic ovary syndrome	7.67e-05	8.16e-05	CbGpPWpGaD
Methylergometrine—DRD1—Signaling Pathways—IRS2—polycystic ovary syndrome	7.67e-05	8.15e-05	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling Pathways—NRG1—polycystic ovary syndrome	7.66e-05	8.14e-05	CbGpPWpGaD
Methylergometrine—DRD1—Signaling Pathways—LEP—polycystic ovary syndrome	7.51e-05	7.98e-05	CbGpPWpGaD
Methylergometrine—CYP3A4—Metabolism—HMMR—polycystic ovary syndrome	7.48e-05	7.95e-05	CbGpPWpGaD
Methylergometrine—HTR1F—Signaling Pathways—VEGFA—polycystic ovary syndrome	7.31e-05	7.76e-05	CbGpPWpGaD
Methylergometrine—CYP3A4—Metabolism—HSD3B1—polycystic ovary syndrome	7.14e-05	7.59e-05	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling Pathways—GNAS—polycystic ovary syndrome	7.12e-05	7.56e-05	CbGpPWpGaD
Methylergometrine—HTR2B—Signaling Pathways—IRS1—polycystic ovary syndrome	7.1e-05	7.55e-05	CbGpPWpGaD
Methylergometrine—HTR1E—Signaling Pathways—VEGFA—polycystic ovary syndrome	6.89e-05	7.32e-05	CbGpPWpGaD
Methylergometrine—HTR2B—Signaling Pathways—POMC—polycystic ovary syndrome	6.84e-05	7.27e-05	CbGpPWpGaD
Methylergometrine—HTR2B—Signaling Pathways—INS—polycystic ovary syndrome	6.8e-05	7.23e-05	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling Pathways—NCOR1—polycystic ovary syndrome	6.78e-05	7.2e-05	CbGpPWpGaD
Methylergometrine—DRD1—Signaling Pathways—IRS1—polycystic ovary syndrome	6.7e-05	7.12e-05	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling Pathways—NRG1—polycystic ovary syndrome	6.65e-05	7.07e-05	CbGpPWpGaD
Methylergometrine—HTR2B—Signaling Pathways—IGF1—polycystic ovary syndrome	6.58e-05	6.99e-05	CbGpPWpGaD
Methylergometrine—HTR2B—Signaling Pathways—AKT2—polycystic ovary syndrome	6.57e-05	6.99e-05	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling Pathways—IRS2—polycystic ovary syndrome	6.56e-05	6.98e-05	CbGpPWpGaD
Methylergometrine—CYP3A4—Metabolism—LHB—polycystic ovary syndrome	6.51e-05	6.92e-05	CbGpPWpGaD
Methylergometrine—DRD1—Signaling Pathways—POMC—polycystic ovary syndrome	6.45e-05	6.86e-05	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling Pathways—LEP—polycystic ovary syndrome	6.42e-05	6.83e-05	CbGpPWpGaD
Methylergometrine—DRD1—Signaling Pathways—INS—polycystic ovary syndrome	6.41e-05	6.82e-05	CbGpPWpGaD
Methylergometrine—CYP3A4—Metabolism—HSD3B2—polycystic ovary syndrome	6.36e-05	6.76e-05	CbGpPWpGaD
Methylergometrine—HTR2B—Signaling Pathways—SERPINE1—polycystic ovary syndrome	6.25e-05	6.64e-05	CbGpPWpGaD
Methylergometrine—DRD1—Signaling Pathways—IGF1—polycystic ovary syndrome	6.2e-05	6.59e-05	CbGpPWpGaD
Methylergometrine—DRD1—Signaling Pathways—AKT2—polycystic ovary syndrome	6.2e-05	6.59e-05	CbGpPWpGaD
Methylergometrine—CYP3A4—Metabolism—AKR1C1—polycystic ovary syndrome	6.16e-05	6.55e-05	CbGpPWpGaD
Methylergometrine—DRD1—Signaling Pathways—SERPINE1—polycystic ovary syndrome	5.89e-05	6.26e-05	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling Pathways—IRS1—polycystic ovary syndrome	5.73e-05	6.09e-05	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling Pathways—IRS2—polycystic ovary syndrome	5.7e-05	6.06e-05	CbGpPWpGaD
Methylergometrine—CYP3A4—Metabolism—SULT2A1—polycystic ovary syndrome	5.67e-05	6.03e-05	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling Pathways—LEP—polycystic ovary syndrome	5.58e-05	5.93e-05	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling Pathways—POMC—polycystic ovary syndrome	5.52e-05	5.86e-05	CbGpPWpGaD
Methylergometrine—CYP3A4—Metabolism—RRM2—polycystic ovary syndrome	5.49e-05	5.84e-05	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling Pathways—INS—polycystic ovary syndrome	5.49e-05	5.83e-05	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling Pathways—IGF1—polycystic ovary syndrome	5.31e-05	5.64e-05	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling Pathways—AKT2—polycystic ovary syndrome	5.3e-05	5.64e-05	CbGpPWpGaD
Methylergometrine—CYP3A4—Metabolism—YAP1—polycystic ovary syndrome	5.29e-05	5.63e-05	CbGpPWpGaD
Methylergometrine—CYP3A4—Metabolism—NAMPT—polycystic ovary syndrome	5.09e-05	5.41e-05	CbGpPWpGaD
Methylergometrine—HTR1F—Signaling Pathways—IL6—polycystic ovary syndrome	5.05e-05	5.37e-05	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling Pathways—SERPINE1—polycystic ovary syndrome	5.04e-05	5.36e-05	CbGpPWpGaD
Methylergometrine—HTR2B—Signaling by GPCR—IL6—polycystic ovary syndrome	5.03e-05	5.35e-05	CbGpPWpGaD
Methylergometrine—CYP3A4—Metabolism—CYP11A1—polycystic ovary syndrome	5.02e-05	5.34e-05	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling Pathways—IRS1—polycystic ovary syndrome	4.98e-05	5.29e-05	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling Pathways—POMC—polycystic ovary syndrome	4.79e-05	5.09e-05	CbGpPWpGaD
Methylergometrine—HTR1E—Signaling Pathways—IL6—polycystic ovary syndrome	4.77e-05	5.07e-05	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling Pathways—INS—polycystic ovary syndrome	4.76e-05	5.06e-05	CbGpPWpGaD
Methylergometrine—DRD1—Signaling by GPCR—IL6—polycystic ovary syndrome	4.74e-05	5.04e-05	CbGpPWpGaD
Methylergometrine—CYP3A4—Metabolism—AKR1C3—polycystic ovary syndrome	4.74e-05	5.04e-05	CbGpPWpGaD
Methylergometrine—CYP3A4—Metabolism—CYP17A1—polycystic ovary syndrome	4.67e-05	4.96e-05	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling Pathways—IGF1—polycystic ovary syndrome	4.61e-05	4.9e-05	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling Pathways—AKT2—polycystic ovary syndrome	4.61e-05	4.89e-05	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling Pathways—SERPINE1—polycystic ovary syndrome	4.38e-05	4.65e-05	CbGpPWpGaD
Methylergometrine—HTR2B—Signaling Pathways—VEGFA—polycystic ovary syndrome	4.3e-05	4.57e-05	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling by GPCR—IL6—polycystic ovary syndrome	4.06e-05	4.31e-05	CbGpPWpGaD
Methylergometrine—DRD1—Signaling Pathways—VEGFA—polycystic ovary syndrome	4.05e-05	4.31e-05	CbGpPWpGaD
Methylergometrine—CYP3A4—Metabolism—TH—polycystic ovary syndrome	4.04e-05	4.29e-05	CbGpPWpGaD
Methylergometrine—CYP3A4—Metabolism—SLC2A4—polycystic ovary syndrome	3.93e-05	4.18e-05	CbGpPWpGaD
Methylergometrine—CYP3A4—Metabolism—CYP19A1—polycystic ovary syndrome	3.7e-05	3.93e-05	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling by GPCR—IL6—polycystic ovary syndrome	3.52e-05	3.75e-05	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling Pathways—VEGFA—polycystic ovary syndrome	3.47e-05	3.68e-05	CbGpPWpGaD
Methylergometrine—CYP3A4—Metabolism—GNAS—polycystic ovary syndrome	3.3e-05	3.51e-05	CbGpPWpGaD
Methylergometrine—CYP3A4—Metabolism—NCOR1—polycystic ovary syndrome	3.14e-05	3.34e-05	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling Pathways—VEGFA—polycystic ovary syndrome	3.01e-05	3.2e-05	CbGpPWpGaD
Methylergometrine—CYP3A4—Metabolism—CYP1A1—polycystic ovary syndrome	2.98e-05	3.17e-05	CbGpPWpGaD
Methylergometrine—HTR2B—Signaling Pathways—IL6—polycystic ovary syndrome	2.97e-05	3.16e-05	CbGpPWpGaD
Methylergometrine—DRD1—Signaling Pathways—IL6—polycystic ovary syndrome	2.8e-05	2.98e-05	CbGpPWpGaD
Methylergometrine—CYP3A4—Metabolism—MTHFR—polycystic ovary syndrome	2.78e-05	2.95e-05	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling Pathways—IL6—polycystic ovary syndrome	2.4e-05	2.55e-05	CbGpPWpGaD
Methylergometrine—CYP3A4—Metabolism—PPARG—polycystic ovary syndrome	2.25e-05	2.39e-05	CbGpPWpGaD
Methylergometrine—CYP3A4—Metabolism—POMC—polycystic ovary syndrome	2.22e-05	2.36e-05	CbGpPWpGaD
Methylergometrine—CYP3A4—Metabolism—INS—polycystic ovary syndrome	2.21e-05	2.35e-05	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling Pathways—IL6—polycystic ovary syndrome	2.08e-05	2.21e-05	CbGpPWpGaD
